886 related articles for article (PubMed ID: 26703953)
1. Biomarker discovery in mass spectrometry-based urinary proteomics.
Thomas S; Hao L; Ricke WA; Li L
Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
[TBL] [Abstract][Full Text] [Related]
2. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
Findeisen P; Neumaier M
Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of urinary proteomics/peptidomics.
Albalat A; Mischak H; Mullen W
Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
[TBL] [Abstract][Full Text] [Related]
5. Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments.
Metzger J; Schanstra JP; Mischak H
Anal Bioanal Chem; 2009 Mar; 393(5):1431-42. PubMed ID: 18704377
[TBL] [Abstract][Full Text] [Related]
6. The impact of advanced proteomics in the search for markers and therapeutic targets of bladder cancer.
Zhang H; Fan Y; Xia L; Gao C; Tong X; Wang H; Sun L; Ji T; Jin M; Gu B; Fan B
Tumour Biol; 2017 Mar; 39(3):1010428317691183. PubMed ID: 28345451
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.
Hawkridge AM; Muddiman DC
Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():265-77. PubMed ID: 20636062
[TBL] [Abstract][Full Text] [Related]
8. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
9. Human urine proteome: a powerful source for clinical research.
Zou L; Sun W
Adv Exp Med Biol; 2015; 845():31-42. PubMed ID: 25355567
[TBL] [Abstract][Full Text] [Related]
10. Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform.
Schiffer E; Mischak H; Theodorescu D; Vlahou A
World J Urol; 2008 Feb; 26(1):67-74. PubMed ID: 18175124
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults.
Ostermann M; McCullough PA; Forni LG; Bagshaw SM; Joannidis M; Shi J; Kashani K; Honore PM; Chawla LS; Kellum JA;
Crit Care Med; 2018 Mar; 46(3):375-383. PubMed ID: 29189343
[TBL] [Abstract][Full Text] [Related]
12. Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
Stepczynska A; Schanstra JP; Mischak H
Bioanalysis; 2016; 8(5):439-55. PubMed ID: 26891752
[TBL] [Abstract][Full Text] [Related]
13. Urine sample preparation in 96-well filter plates to characterize inflammatory and infectious diseases of the urinary tract.
Yu Y; Pieper R
Adv Exp Med Biol; 2015; 845():77-87. PubMed ID: 25355571
[TBL] [Abstract][Full Text] [Related]
14. Targeted mass spectrometry approaches for protein biomarker verification.
Meng Z; Veenstra TD
J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
[TBL] [Abstract][Full Text] [Related]
15. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry based proteomics in urine biomarker discovery.
Theodorescu D; Mischak H
World J Urol; 2007 Oct; 25(5):435-43. PubMed ID: 17703310
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of renal function, which and when?
Wasung ME; Chawla LS; Madero M
Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle arrest biomarkers: new weapons for a new battle.
Ronco C
Blood Purif; 2014; 38(3-4):I-III. PubMed ID: 25678359
[No Abstract] [Full Text] [Related]
19. Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation.
Albalat A; Mischak H; Mullen W
Prilozi; 2011; 32(1):13-44. PubMed ID: 21822176
[TBL] [Abstract][Full Text] [Related]
20. Practical points in urinary proteomics.
Thongboonkerd V
J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
